Catalio Capital Management, a multi-strategy life sciences investment firm, announced the launch of their Credit Opportunities strategy to expand the scope of the firm’s investments across the biomedical technology industry and meet the growing...
Read Story
February 03, 2021, 07:50 AM
|
Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it has entered into a $50 million senior...
Read Story
July 17, 2017, 07:17 AM
|
Oxford BioMedica PLC has signed a new $55.0 million debt facility with Oaktree Capital Management. The facility has been used to redeem the existing debt facility with Oberland Capital Healthcare.The loan is repayable no later than 29 June 2020...
Read Story
July 05, 2017, 07:22 AM
|